A na-eji 3- (1- (Dimethylamino) ethyl] phenol dị ka etiti nke Rivastigmine tartrate.
Rivastigmine tartrate bụ rivastigmine ọrịa Alzheimer ọgwụ, rivastigmine bụ physostigmine derivative site Novartis maka oge mbụ ọma mepụtara ahia aha Exelon (exelon), a molekul na e nwere carbamate Ọdịdị, bụ ụdị amino acid nke cholinesterase inhibitor na-ahọrọ, nwekwara ike igbochi. na acetylcholinesterase na butyrylcholinesterase, cholinergic neurons site na-egbu oge ntọhapụ nke acetylcholine mmebi na ume na-akwalite cholinergic akwara conduction, nwere ike melite cognition ọrụ ọrịa ogbugbo site cholinergic, si otú imeziwanye cognitive ọrụ nke ọrịa Alzheimer.Njikọ protein Rivastigmine plasma adịghị ike, dị mfe site na mgbochi ụbụrụ ọbara, nke nwere oke nhọrọ ụbụrụ.Ọ bụghị naanị na ọ na-ahọrọ nke ọma na cortex cerebral cortex na hippocampus na-emetụta nke ọma, kamakwa ọ na-egbochikwa subtype nke AChE na ụbụrụ ụbụrụ, na-ebute mbelata arụmọrụ nke mmetụta cholinergic peripheral.Rivastigmine in vivo ọkara ndụ dị mkpụmkpụ na ogologo oge nke ime ihe.N'adịghị ka tacrine, ngwaahịa a na hippocampus na cortex nke mmetụta inhibitory enzyme G1 siri ike karị.A na-enyo enyo na ụlọ ọgwụ maka ọgwụgwọ ụdị mgbaka Alzheimer dị nro ma na-agafeghị oke, ma ọ bụ ọrịa Alzheimer nwere ike iche na ọ bụ ọrịa Alzheimer n'ụlọ ọgwụ.